Pharma Sales reps – what rewards do they most prefer?
Pharma Sales reps – don’t delete documents!
Eli Lilly garners unwanted news coverage of possible behind-the-scenes discussion of unapproved uses for Zyprexa. NY Times does its bit here; Lilly issues denial here. Meanwhile, former Eli Lilly drug rep talks to Congressional committee about sales practices: Shahram Ahari, who spent two years selling Prozac and Zypraxa for Eli Lily, told a Senate Aging Committee chaired by Sen. Herb Kohl, D-Wisc., that his job involved “rewarding physicians with gifts and attention for their allegiance to your product and company despite what may be ethically appropriate.”
J&J warns of liver risk with HIV treatment Prezista.
Wyeth – drug approval setbacks.
Another potential obesity drug (from Merck) looking like it won’t be a heavyweight.
Type 2 diabetes – is it an intestinal thing? Interesting study showing the gastric bypass surgery can cause diabetes remission irrespective of other factors.
GSK to get priority review (in Europe) for new platelet boosting drug Promacta.